Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Donald Seaton, James Garner, Fraser Logue

Premium

Integrated Diagnostics announced this week the appointment of Donald Seaton as its chief financial officer and James Garner as its chief business officer.

Seaton brings to the company more than two decades of experience as a biotech executive and was previously the chief financial officer and chief operating officer at EndoGastric Solutions. Garner, meanwhile, has been consulting Integrated Diagnostics for more than a year. Prior to joining the company, Garner was senior VP of global sales and i3 research at UnitedHealth Group.

With these appointments, Integrated Diagnostics has fully formed its executive team, the company said.


UK-based Lab21 has appointed Fraser Logue as the company's group director of quality, regulatory affairs and operations excellence. Previously, Logue worked within various divisions of Abbott Laboratories. Most recently, he was division VP of worldwide manufacturing of Abbott's diabetes care division.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.